Biopharmaceutical characterization of oral immediate release drug products. In vitro/in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 46, Issue 3, 1998, Pages 305-311

  Frick, Annke ^a   Möller, Helga ^a   Wirbitzki, Ehrenfried ^a  

^a SANOFI   (France)

Author keywords

Biopharmaceutical characterization; Dissolution; Glimepiride; In vivo studies; Levofloxacin; Oral immediate release drug products; Permeability; Phenoxymethylpenicillin potassium; Solubility

Indexed keywords

GLIMEPIRIDE; LEVOFLOXACIN; PENICILLIN V; PENICILLIN V POTASSIUM;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SUSTAINED DRUG RELEASE;

ABSORPTION; ADMINISTRATION, ORAL; ANTI-INFECTIVE AGENTS; BIOLOGICAL AVAILABILITY; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; CHEMISTRY, PHYSICAL; CROSS-OVER STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; OFLOXACIN; PENICILLIN V; PENICILLINS; SOLUBILITY; SULFONYLUREA COMPOUNDS;

EID: 0032214518     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(98)00041-1     Document Type: Article

References (19)

1. Rudman A., Lesko L., Malinowski H., Roy S., Williams R.L. Immediate release solid oral dosage forms. Scale-up and postapproval changes. Guidance for industry, chemistry, manufacturing, and controls. In vitro dissolution testing, in vivo bioequivalence documentation. Pharm. Technol. 3:1996;50-61.
2. USP 23, General Information, in: In Vitro and In Vivo Evaluation of Dosage Forms.
3. S.V. Dighe, Development of dissolution tests for immediate release and modified release oral dosage forms, Med. Pharm. Scientific Publishers, Stuttgart, 1995.
4. FIP Guidelines for Dissolution Testing of Solid Oral Products, Draft. 1997.
5. International Conference on Harmonisation (ICH 2), Orlando, Florida, 1993.
6. Möller H., Wirbitzki E. Validation of in vitro dissolution. S.T.P. Pharma. Practiques. 5:1993;348-352.
7. International Conference on Harmonisation (ICH 3), Guidelines for Validation of Analytical Procedures, Yokohama, Japan, 1995.
8. Amidon G.L., Lennernas H., Shah V.P., Crison J. A theoretical basis for a biopharmaceutical drug classification: The correlation of in vitro drug product dissolution and in vitro bioavailability. Pharm. Res. 12:1995;413-417.
9. Amidon et al., AAPS-CRS-FDA-Workshop on Scientific Foundation and Applications for the Biopharmaceutics Classification System and In Vitro-In Vivo Correlations, (April 1997, Arlington VA).
10. Oh D.M., Curl R.L., Amidon G.L. Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model. Pharm. Res. 10:1993;264-268.
11. Wilson G., Hassan I.F., Dix C.J., Williamson I., Shah R., Mackay M. Transport and permeability properties of human CaCo-2 cells: an in vitro model of intestinal epithelial cell barrier. J. Control. Rel. 11:1990;25-32.
12. A. Frick, Methods to assess intestinal absorption in drug discovery, Doctoral thesis (in preparation).
13. Boulenc X., Breul T., Gautier J.C., Saudemon P., Joyeux H., Roques C., Berger Y., Fabre G. Sodium lauryl sulfate increases tiludronate paracellular transport using human epithelial CaCo-2 monolayers. Int. J. Pharm. 123:1995;71-78.
14. Walter E., Janich S., Roessler B.J., Hilfinger J.M., Amidon G.L. HT29-MXT- CaCo-2-cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans. J. Pharm. Sci. 85:1996;1070-1077.
15. Bauer B., Malerczyk V., Roethig H.J. Bioavailability of a new formulation of penicillin V (Isocillin® syrup) and the influence of ethanol on bioavailability of penicillin V. Int. J. Clin. Pharm. Ther. Tox. 27:1989;583-587.
16. Badian M., Korn A., Lehr K.H., Malerczyk V., Waldhäusel W. Absolute bioavailability of glimepiride (Amaryl®) after oral administration. Drug Metab. Drug Int. 4:1994;331-339.
17. Internal Report (Hoechst Marion Roussel Deutschland GmbH).
18. The Pharmaceutical Codex, seventh ed., Pharmaceutical Press, London 1994.
19. Artursson P., Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (CaCo-2) cells. Biochem. Biophys. Res. Com. 3:1991;880-889.